Quantori
Private Company
Total funding raised: $10M
Overview
Quantori is a specialized technology services and platform provider for the biopharma and healthcare industries, operating at the intersection of advanced AI and deep scientific domain knowledge. The company has evolved from a pure IT services model to develop its own proprietary AI platform, Q-Suite, which includes predictive ADMET models and agentic AI tools designed to accelerate R&D. With a client base that includes 12 of the top 15 pharmaceutical companies and over 30 innovative startups, Quantori leverages a globally distributed team of engineers, data scientists, and MDs/PhDs to deliver scalable, AI-enabled solutions that address complex challenges from discovery to delivery.
Technology Platform
Q-Suite™, a modular agentic AI platform for life sciences featuring Q-Models (predictive ADMET ML models), Q-Scientist (digital lab automation), and Q-Portal (governance for LLMs).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Quantori competes in a crowded field including global IT and consulting giants (e.g., Accenture, IQVIA), specialized bioinformatics software companies (e.g., DNAnexus, Benchling), and pure-play AI/ML drug discovery platforms (e.g., Schrödinger, Recursion, Exscientia). Its differentiation lies in its deep scientific domain expertise combined with full-stack engineering services and its emerging focus on agentic AI platforms tailored for life sciences.